Filter posts

2011: A Pivotal Year for Biotechnology

Biotechnology continues to hold the greatest promise to address many of the most critical issues …

2012: A Critical Year for Biotechnology

In 2012, we must continue to look for ways to reduce risk; enhance reward; reduce …

Biomedical Innovation: How the U.S. Can Stay Number One

By Ross DeVol, chief research officer of the Milken Institute “The first step in winning …

Medical Innovation at Risk

The National Venture Capital Association’s MedIC Coalition recently released a report showing U.S. venture capitalists …

Moving Beyond the Stem Cell Stalemate

By Michael J. Werner, Alliance for Regenerative Medicine For the past several years, attendees at the …

The Burrill Report: Pushing Policies in a Changed Washington

The Burrill Report’s Daniel Levine talks to BIO’s Alan Eisenberg regarding recent fluctuations in the …

How to grow the economy and feed the world

By Barbara Wells, President and CEO, ArborGen Chair, BIO Food and Agriculture Section Governing Board …

FDA: How can we improve it?

By Stephen Sherwin, Former Chairman of BIO As Congress and the President work together to hammer out …

How we are advancing American innovation to cure disease and save lives

Mankind’s need to cure disease, combat hunger and discover new forms of energy has never …